Executive Vice President, Bioscience Business Unit at Greiner Bio-One

Former Executive Vice President of the Bioscience Business Unit at Greiner Bio-One with nearly 30 years in bioprocessing across Thermo Fisher, Lonza, Millipore, and Repligen, where he led the capital equipment business and reported to the CEO. Brings deep expertise across upstream and downstream unit operations spanning monoclonal antibodies, vaccines, cell and gene therapy, and emerging modalities, with extensive geographic exposure across the US, Europe, and Asia-Pacific markets.